- Report
- August 2026
- 350 Pages
Global
From €5254EUR$5,850USD£4,488GBP
- Report
- February 2026
- 160 Pages
Global
From €2982EUR$3,320USD£2,547GBP
€3727EUR$4,150USD£3,184GBP
- Report
- June 2025
- 405 Pages
Global
From €4042EUR$4,500USD£3,453GBP
- Report
- August 2025
- 192 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- October 2024
- 131 Pages
Asia Pacific
From €3593EUR$4,000USD£3,069GBP
- Report
- December 2021
- 153 Pages
Global
From €3997EUR$4,450USD£3,414GBP
- Report
- October 2024
- 86 Pages
From €2650EUR$2,950USD£2,263GBP
- Report
- November 2022
- 150 Pages
Global
From €4042EUR$4,500USD£3,453GBP
- Report
- August 2025
- 146 Pages
Global
From €2084EUR$2,320USD£1,780GBP
€2605EUR$2,900USD£2,225GBP
- Report
- September 2024
- 99 Pages
Global
From €3500EUR$4,174USD£3,094GBP

Omega-3 Polyunsaturated Fatty Acids (PUFAs) are a type of fatty acid found in fish oil and other marine sources. They are essential for human health and have been linked to a variety of mental disorders, including depression, bipolar disorder, and schizophrenia. Studies have shown that Omega-3 PUFAs can help reduce symptoms of mental disorders, such as anxiety and depression, and may even help prevent them from developing in the first place.
Omega-3 PUFAs are available in a variety of forms, including capsules, tablets, and liquid supplements. They can also be found in certain foods, such as fish, flaxseed, and walnuts. Many companies have developed products containing Omega-3 PUFAs specifically for mental disorders, such as Nordic Naturals, Jarrow Formulas, and Carlson Labs. These products are widely available in health food stores, pharmacies, and online retailers.
Some of the major companies in the Omega-3 PUFA market include Amarin Corporation, BASF, DSM, and Omega Protein Corporation. These companies produce a variety of Omega-3 PUFA products, including fish oil supplements, pharmaceuticals, and food ingredients. Show Less Read more